Around 50% of the cases were stained PD-L2+ on tumor cells, with 30% resulting in PD-L2high (> 50% positive cells) and is associated with an EGFR mutation and a lower stage of the tumor. The gene discussed is PDCD1LG2; the disease is neoplasm.